[糖M1和/或M4受体激活剂作为潜在的新型治疗精神病]
Tijdschrift voor psychiatrie
|November 10, 2023
概括
新的研究表明,准胆固醇肌肉蛋白1 (M1) 和肌肉蛋白4 (M4) 受体可能为精神病障碍提供新的治疗方法. 像xanomeline和emraclidine这样的药物显示出改善症状的希望.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 胆固醇肌肉蛋白1 (M1) 和肌肉蛋白4 (M4) 受体与精神疾病的病理生理学有关.
- 这些受体的激应调节为精神病提供了潜在的治疗途径.
研究的目的:
- 审查目前关于M1和M4受体在精神病发展和治疗中的作用的研究.
- 突出新药候选药物,包括诺梅林和埃姆拉克利丁,准这些受体.
主要方法:
- 在PubMed,Embase和PsycInfo的系统文献搜索,截至2023年6月1日.
- 对研究M1和/或M4激动剂在精神分裂症中的研究进行分析.
- 查询临床试验注册表,以进行正在进行的研究.
主要成果:
- 减少的M1受体 (额叶皮层) 和M4受体 (基底腺) 与精神病有关.
- M1和M4受体调节与精神病相关的多巴胺活性.
- 赞诺梅林-托斯皮乌姆和埃姆拉克利丁在精神分裂症患者的认知和负面症状上表现出积极的影响.
结论:
- M1和/或M4受体激活剂代表了精神病障碍的有前途的新治疗策略.
- 克萨诺梅林-托斯皮乌姆和埃姆拉克利丁显示出早期积极的结果,需要进一步调查.
- 这些新药的长期疗效,安全性和耐受性需要全面评估.
更多相关视频
08:20MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
13.9K
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
9.9K
相关概念视频
Antiasthma Drugs: Muscarinic Receptor Antagonists
316
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
316
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.4K
Cholinergic Antagonists: Therapeutic Uses
758
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
758
Psychosis and Antipsychotic Drugs: Overview
289
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
289
Cholinergic Antagonists: Pharmacological Actions
1.1K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.1K
Psychosis: Goals of Pharmacotherapy
143
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
143
